Research programme: tri-functional proteins - KAHR Medical
Alternative Names: TSP - KAHR MedicalLatest Information Update: 22 Mar 2021
At a glance
- Originator KAHR Medical
- Class Antineoplastics; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 01 Sep 2020 Early research in Cancer in Israel (Parenteral) (KAHR Bio pipeline, September 2020)